Method of Administration for Intravenous Amiodarone
Administer IV amiodarone through a central venous catheter whenever possible using a volumetric infusion pump with an in-line filter, diluted in D5W at concentrations not exceeding 2 mg/mL for peripheral access or infusions longer than 1 hour. 1
Route and Access Requirements
- Use a central venous catheter dedicated to amiodarone administration whenever possible to minimize the risk of severe peripheral vein phlebitis, which occurs frequently with concentrations >2 mg/mL 1
- For concentrations >2 mg/mL, a central line is mandatory 2
- Peripheral venous access may be used only if concentrations are ≤2 mg/mL and infusion duration is ≤1 hour 1
Infusion Equipment and Preparation
- Amiodarone must be delivered by a volumetric infusion pump - never use drop counter infusion sets, as altered surface properties can reduce drop size and cause up to 30% underdosing 1
- Use an in-line filter during all administrations 1
- Administer infusions exceeding 2 hours in glass or polyolefin bottles containing D5W only 1
- Do not use evacuated glass containers for admixing, as buffer incompatibility may cause precipitation 1
Standard Dosing Protocol for Life-Threatening Ventricular Arrhythmias
Initial Loading (First 24 Hours)
- Loading dose: 150 mg IV over 10 minutes, followed by 1 mg/min for 6 hours, then 0.5 mg/min for the remaining 18 hours (total ~1000 mg over 24 hours) 2, 1
- Do not exceed an initial infusion rate of 30 mg/min 1
- Mean daily doses above 2100 mg are associated with increased risk of hypotension 1
Maintenance Infusion (After 24 Hours)
- Continue at 0.5 mg/min (720 mg per 24 hours) using concentrations of 1-6 mg/mL 1
- Maintenance infusion up to 0.5 mg/min can be continued for 2-3 weeks regardless of age, renal function, or left ventricular function 1
Breakthrough Arrhythmias
- For breakthrough VF or hemodynamically unstable VT: administer 150 mg supplemental bolus mixed in 100 mL D5W infused over 10 minutes 1
Cardiac Arrest Protocol (VF/Pulseless VT)
- For cardiac arrest unresponsive to defibrillation and epinephrine: 300 mg IV/IO bolus over 10 minutes, with a second 150 mg bolus if rhythm persists 2
- In pediatric patients: 5 mg/kg rapid bolus (maximum 300 mg) IV/IO, may repeat up to total daily dose of 15 mg/kg 3
Critical Monitoring Requirements
- Continuous ECG monitoring is mandatory during all amiodarone administration to detect bradycardia (occurs in 4.9% of IV patients), AV block, heart block, QT prolongation, and hypotension (occurs in 16% of IV patients) 2, 4
- A defibrillator must be immediately available 3
- Monitor blood pressure continuously during loading doses 2
- Watch for phlebitis at infusion site, particularly with peripheral access 2
Absolute Contraindications
- Do not administer without a pacemaker in patients with: second- or third-degree AV block, sick sinus syndrome, or severe sinus node dysfunction 3, 4
- Contraindicated in patients who have had a heart transplant 3
Important Administration Caveats
- Amiodarone adsorbs to PVC tubing, but all clinical dosing recommendations account for this effect 1
- The drug leaches plasticizers (DEHP) from IV tubing, particularly at higher concentrations and lower flow rates 1
- Amiodarone does not require light protection during administration 1
- Inspect solution before administration - it should be clear 1
- Never use plastic containers in series connections, as this can cause air embolism 1
Common Pitfalls to Avoid
- Loading infusions at concentrations and rates much higher than recommended have resulted in hepatocellular necrosis, acute renal failure, and death 1
- Concentrations >3 mg/mL in D5W are associated with high incidence of peripheral vein phlebitis 1
- If bradycardia or heart block develops, discontinue the infusion or reduce the rate immediately 4
- Reduce digoxin dose by 50% when starting amiodarone, as digoxin levels predictably double 4
- Reduce warfarin dose by 30-50% and check INR within 3-5 days, as amiodarone significantly increases anticoagulation effects 4